KING OF PRUSSIA, Pa., March 9, 2010 (GLOBE NEWSWIRE) -- Emergent Health Corp. (Pink Sheets:EMGE) (the "Company") is pleased to announce the appointment of three new Board Members as of March 4, 2010. They are:
The Company is excited about these new appointments and continues efforts to further strengthen its management team.
The Company has developed a new video to promulgate corporate presence and direction http://video214.com/play/XUAtWHy0U8Ty4tgTte5RjQ/s/dark. Distributor interests are always welcome.
See the new video on the Company's patented Vita-Stim(TM) Stem Cell Nutrition product here http://video214.com/play/ie4Gtcm0ncA1RZ8ByDpGFA/s/dark. The Vita-Stim(TM) product website is: http://www.vita-stim.com
About Emergent Health Corp.
Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, Emergent believes it is positioning itself as a leader in the field of Regenerative Medicine as defined by the National Institute of Health.
Sign up for Free Newsletter Updates here: http://emergenthealth.com
This press release contains certain "forward-looking" statements, defined in the United States Private Securities Litigation Reform Act of 1995, that involve a number of risks and uncertainties. Statements, which are not historical facts, are forward-looking statements. The company, through its management, makes forward-looking public statements concerning its expected future operations, performance and other developments. Such forward-looking statements are estimates reflecting the company's best judgment based upon current information and involve a number of risks and uncertainties and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. It is impossible to identify all such factors that could cause actual results to differ materially from those estimated by the company.
This press release is provided for information purposes only and is not intended to constitute an offer to sell or a solicitation of an offer to buy securities.
CONTACT: Emergent Health Corp. Investor Relations 866-427-6143 King of Prussia, PA 19406